Community carriage of ESBL-producing Escherichia coli and Klebsiella pneumoniae: a cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates

被引:10
|
作者
Raffelsberger, Niclas [1 ,2 ]
Buczek, Dorota Julia [2 ]
Svendsen, Kristian [3 ]
Smabrekke, Lars [3 ]
Pontinen, Anna Kaarina H. [4 ,5 ]
Lohr, Iren [6 ]
Andreassen, Lotte Leonore Eivindsdatter [1 ]
Simonsen, Gunnar Skov [1 ,2 ]
Sundsfjord, Arnfinn [2 ,4 ]
Gravningen, Kirsten [1 ,7 ,8 ]
Samuelsen, Orjan [3 ,4 ]
机构
[1] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway
[3] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Tromso, Norway
[4] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway
[5] Univ Oslo, Dept Biostat, Oslo, Norway
[6] Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway
[7] Akershus Univ Hosp, Dept Microbiol & Infect Control, Nordbyhagen, Norway
[8] Univ Oslo, Inst Clin Med, Div Med & Lab Sci, Oslo, Norway
关键词
Escherichia coli; Klebsiella pneumoniae; extended-spectrum beta-lactamase; antimicrobial resistance; carriage; risk factors; general population; bacterial genomics; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; BLOOD-STREAM INFECTIONS; FECAL COLONIZATION; PREVALENCE; NORWAY; RESISTANCE; NATIONWIDE; EMERGENCE; MORTALITY; THERAPY;
D O I
10.1128/msphere.00025-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The global prevalence of infections caused by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) is increasing, and for Escherichia coli, observations indicate that this is partly driven by community-onset cases. The ESBL-E population structure in the community is scarcely described, and data on risk factors for carriage are conflicting. Here, we report the prevalence and population structure of fecal ESBL-producing E. coli and Klebsiella pneumoniae (ESBL-Ec/Kp) in a general adult population, examine risk factors, and compare carriage isolates with contemporary clinical isolates. Fecal samples obtained from 4,999 participants (54% women) >= 40 years in the seventh survey of the population-based Tromso Study, Norway (2015, 2016), were screened for ESBL-Ec/Kp. In addition, we included 118 ESBL-Ec clinical isolates from the Norwegian surveillance program in 2014. All isolates were whole-genome sequenced. Risk factors associated with carriage were analyzed using multivariable logistic regression. ESBL-Ec gastrointestinal carriage prevalence was 3.3% [95% confidence interval (CI) 2.8%-3.9%, no sex difference] and 0.08% (0.02%-0.20%) for ESBL-Kp. For ESBL-Ec, travel to Asia was the only independent risk factor (adjusted odds ratio 3.46, 95% CI 2.18-5.49). E. coli ST131 was most prevalent in both collections. However, the ST131 proportion was significantly lower in carriage (24%) versus clinical isolates (58%, P < 0.001). Carriage isolates were genetically more diverse with a higher proportion of phylogroup A (26%) than clinical isolates (5%, P < 0.001), indicating that ESBL gene acquisition occurs in a variety of E. coli lineages colonizing the gut. STs commonly related to extraintestinal infections were more frequent in clinical isolates also carrying a higher prevalence of antimicrobial resistance, which could indicate clone-associated pathogenicity. IMPORTANCE ESBL-Ec and ESBL-Kp are major pathogens in the global burden of antimicrobial resistance. However, there is a gap in knowledge concerning the bacterial population structure of human ESBL-Ec/Kp carriage isolates in the community. We have examined ESBL-Ec/Kp isolates from a population-based study and compared these to contemporary clinical isolates. The large genetic diversity of carriage isolates indicates frequent ESBL gene acquisition, while those causing invasive infections are more clone dependent and associated with a higher prevalence of antibiotic resistance. The knowledge of factors associated with ESBL carriage helps to identify patients at risk to combat the spread of resistant bacteria within the healthcare system. Particularly, previous travel to Asia stands out as a major risk factor for carriage and should be considered in selecting empirical antibiotic treatment in critically ill patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Performance of the Check-Direct ESBL Screen for BD MAX™ for detection of asymptomatic faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae
    Grondahl-Yli-Hannuksela, Kirsi
    Lonnqvist, Emilia
    Marttila, Harri
    Rintala, Esa
    Rantakokko-Jalava, Kaisu
    Vuopio, Jaana
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 408 - 413
  • [42] Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study
    Joshua T Freeman
    Joseph Rubin
    Gary N McAuliffe
    Gisele Peirano
    Sally A Roberts
    Dragana Drinković
    Johann DD Pitout
    Antimicrobial Resistance and Infection Control, 3
  • [43] Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study
    Freeman, Joshua T.
    Rubin, Joseph
    McAuliffe, Gary N.
    Peirano, Gisele
    Roberts, Sally A.
    Drinkovic, Dragana
    Pitout, Johann D. D.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2014, 3
  • [44] ANTIBACTERIAL ACTIVITY OF RHEUM RHAPONTICUM, OLEA EUROPAEA, AND VIOLA ODORATA ON ESBL PRODUCING CLINICAL ISOLATES OF ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
    Ziad, Daoud
    Elias, Abdou
    Roula, Abdel-Massih
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (07): : 1669 - 1678
  • [45] Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit
    Pena, C
    Pujol, M
    Ricart, A
    Ardanuy, C
    Ayats, J
    Linares, J
    Garrigosa, F
    Ariza, J
    Gudiol, F
    JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) : 9 - 16
  • [46] Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark
    Richelsen, Rasmus
    Smit, Jesper
    Schonheyder, Henrik Carl
    Anru, Pavithra Laxsen
    Gutierrez-Gutierrez, Belen
    Rodriguez-Bano, Jesus
    Nielsen, Henrik
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) : 3656 - 3664
  • [47] Recurrent Paediatric Abdominal Pain Associated with ESBL-producing Escherichia coli Attributable to Unscreened use of Empirical Antibiotics: A Cross-sectional Study
    Subudhi, Monalisa
    Das, Sudhanshu kumar
    Padmasree, M.
    Reddy, Uday kiran
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2025, 19 (03) : SC15 - SC19
  • [48] The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors
    Ozgunes, Ilhan
    Erben, Nurettin
    Kiremitci, Abdurahman
    Kartal, Elif D.
    Durmaz, Gul
    Colak, Hasan
    Usluer, Gaye
    Colak, Ertugrul
    SAUDI MEDICAL JOURNAL, 2006, 27 (05) : 608 - 612
  • [49] Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis
    Bezabih, Yihienew M.
    Bezabih, Alemayehu
    Dion, Michel
    Batard, Eric
    Teka, Samson
    Obole, Abiy
    Dessalegn, Noah
    Enyew, Alelegn
    Roujeinikova, Anna
    Alamneh, Endalkachew
    Mirkazemi, Corinne
    Peterson, Gregory M.
    Bezabhe, Woldesellassie M.
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (03):
  • [50] Risk factors for acquisition of ESBL-producing Escherichia coli and Klebsiella pneumoniae on non-ventilator-associated hospital-acquired pneumonia in a tertiary care hospital in Indonesia
    Santosaningsih, Dewi
    Millennie, Helena E.
    Tunjungsari, Diandra P.
    Shalihah, Shafiyyah M.
    Ramadhani, Chintyadewi H.
    Chozin, Iin N.
    Setyawan, Ungky A.
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2022, 18 (04) : 432 - 436